193 related articles for article (PubMed ID: 21497294)
1. Stromal expression of β-arrestin-1 predicts clinical outcome and tamoxifen response in breast cancer.
Lundgren K; Tobin NP; Lehn S; Stål O; Rydén L; Jirström K; Landberg G
J Mol Diagn; 2011 May; 13(3):340-51. PubMed ID: 21497294
[TBL] [Abstract][Full Text] [Related]
2. Gene products of chromosome 11q and their association with CCND1 gene amplification and tamoxifen resistance in premenopausal breast cancer.
Lundgren K; Holm K; Nordenskjöld B; Borg A; Landberg G
Breast Cancer Res; 2008; 10(5):R81. PubMed ID: 18823530
[TBL] [Abstract][Full Text] [Related]
3. Co-amplification of CCND1 and EMSY is associated with an adverse outcome in ER-positive tamoxifen-treated breast cancers.
Brown LA; Johnson K; Leung S; Bismar TA; Benítez J; Foulkes WD; Huntsman DG
Breast Cancer Res Treat; 2010 Jun; 121(2):347-54. PubMed ID: 19636701
[TBL] [Abstract][Full Text] [Related]
4. Amplification of CCND1 and PAK1 as predictors of recurrence and tamoxifen resistance in postmenopausal breast cancer.
Bostner J; Ahnström Waltersson M; Fornander T; Skoog L; Nordenskjöld B; Stål O
Oncogene; 2007 Oct; 26(49):6997-7005. PubMed ID: 17486065
[TBL] [Abstract][Full Text] [Related]
5. RSF1 and not cyclin D1 gene amplification may predict lack of benefit from adjuvant tamoxifen in high-risk pre-menopausal women in the MA.12 randomized clinical trial.
Keilty D; Buchanan M; Ntapolias K; Aleynikova O; Tu D; Li X; Shepherd L; Bramwell V; Basik M
PLoS One; 2013; 8(12):e81740. PubMed ID: 24367492
[TBL] [Abstract][Full Text] [Related]
6. Adverse effect of adjuvant tamoxifen in premenopausal breast cancer with cyclin D1 gene amplification.
Jirström K; Stendahl M; Rydén L; Kronblad A; Bendahl PO; Stål O; Landberg G
Cancer Res; 2005 Sep; 65(17):8009-16. PubMed ID: 16140974
[TBL] [Abstract][Full Text] [Related]
7. β-arrestin 2 is associated with multidrug resistance in breast cancer cells through regulating MDR1 gene expression.
Jing X; Zhang H; Hu J; Su P; Zhang W; Jia M; Cheng H; Li W; Zhou G
Int J Clin Exp Pathol; 2015; 8(2):1354-63. PubMed ID: 25973019
[TBL] [Abstract][Full Text] [Related]
8. The long-term prognostic and predictive capacity of cyclin D1 gene amplification in 2305 breast tumours.
Lundberg A; Lindström LS; Li J; Harrell JC; Darai-Ramqvist E; Sifakis EG; Foukakis T; Perou CM; Czene K; Bergh J; Tobin NP
Breast Cancer Res; 2019 Feb; 21(1):34. PubMed ID: 30819233
[TBL] [Abstract][Full Text] [Related]
9. The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer.
Liu SS; Li Y; Zhang H; Zhang D; Zhang XB; Wang X; Yu Y
Theranostics; 2020; 10(23):10729-10742. PubMed ID: 32929377
[No Abstract] [Full Text] [Related]
10. MYEOV: a candidate gene for DNA amplification events occurring centromeric to CCND1 in breast cancer.
Janssen JW; Cuny M; Orsetti B; Rodriguez C; Vallés H; Bartram CR; Schuuring E; Theillet C
Int J Cancer; 2002 Dec; 102(6):608-14. PubMed ID: 12448002
[TBL] [Abstract][Full Text] [Related]
11. Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis.
Seshadri R; Lee CS; Hui R; McCaul K; Horsfall DJ; Sutherland RL
Clin Cancer Res; 1996 Jul; 2(7):1177-84. PubMed ID: 9816285
[TBL] [Abstract][Full Text] [Related]
12. Beta-arrestin/Ral signaling regulates lysophosphatidic acid-mediated migration and invasion of human breast tumor cells.
Li TT; Alemayehu M; Aziziyeh AI; Pape C; Pampillo M; Postovit LM; Mills GB; Babwah AV; Bhattacharya M
Mol Cancer Res; 2009 Jul; 7(7):1064-77. PubMed ID: 19609003
[TBL] [Abstract][Full Text] [Related]
13. GSK3β and cyclin D1 expression predicts outcome in early breast cancer patients.
Quintayo MA; Munro AF; Thomas J; Kunkler IH; Jack W; Kerr GR; Dixon JM; Chetty U; Bartlett JM
Breast Cancer Res Treat; 2012 Nov; 136(1):161-8. PubMed ID: 22976805
[TBL] [Abstract][Full Text] [Related]
14. Nicotinic acetylcholine receptors induce c-Kit ligand/Stem Cell Factor and promote stemness in an ARRB1/ β-arrestin-1 dependent manner in NSCLC.
Perumal D; Pillai S; Nguyen J; Schaal C; Coppola D; Chellappan SP
Oncotarget; 2014 Nov; 5(21):10486-502. PubMed ID: 25401222
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and predictive value of copy number alterations in invasive breast cancer as determined by multiplex ligation-dependent probe amplification.
Tabarestani S; Ghaderian SM; Rezvani H; Mirfakhraie R; Ebrahimi A; Attarian H; Rafat J; Ghadyani M; Alavi HA; Kamalian N; Rakhsha A; Azargashb E
Cell Oncol (Dordr); 2014 Apr; 37(2):107-18. PubMed ID: 24573687
[TBL] [Abstract][Full Text] [Related]
16. Constitutive protease-activated receptor-2-mediated migration of MDA MB-231 breast cancer cells requires both beta-arrestin-1 and -2.
Ge L; Shenoy SK; Lefkowitz RJ; DeFea K
J Biol Chem; 2004 Dec; 279(53):55419-24. PubMed ID: 15489220
[TBL] [Abstract][Full Text] [Related]
17. CCND1 and FGFR1 gene amplifications are associated with reduced benefit from aromatase inhibitors in metastatic breast cancer.
Aleksakhina SN; Kramchaninov MM; Mikushina AD; Kubrina SE; Petkau VV; Ivantsov AO; Moiseyenko VM; Imyanitov EN; Iyevleva AG
Clin Transl Oncol; 2021 Apr; 23(4):874-881. PubMed ID: 32880048
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of amplification patterns and target genes at chromosome 11q13 in CCND1-amplified sporadic and familial breast tumours.
Holm K; Staaf J; Jönsson G; Vallon-Christersson J; Gunnarsson H; Arason A; Magnusson L; Barkardottir RB; Hegardt C; Ringnér M; Borg A
Breast Cancer Res Treat; 2012 Jun; 133(2):583-94. PubMed ID: 22002566
[TBL] [Abstract][Full Text] [Related]
19. PPFIA1 and CCND1 are frequently coamplified in breast cancer.
Dancau AM; Wuth L; Waschow M; Holst F; Krohn A; Choschzick M; Terracciano L; Politis S; Kurtz S; Lebeau A; Friedrichs K; Wencke K; Monni O; Simon R
Genes Chromosomes Cancer; 2010 Jan; 49(1):1-8. PubMed ID: 19787783
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1, Id1 and EMT in breast cancer.
Tobin NP; Sims AH; Lundgren KL; Lehn S; Landberg G
BMC Cancer; 2011 Sep; 11():417. PubMed ID: 21955753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
